Former Wayne State Cancer Researcher Lodges 19th Retraction

Fazlul Sarkar had unsuccessfully sued PubPeer to reveal the identity of a commenter who accused him of research misconduct.

By | January 2, 2018

books on shelfPIXABAY, DELPHINMEDIAA cancer researcher formerly found by a Wayne State University investigative committee to have engaged in research misconduct has racked up his 19th paper retraction, Retraction Watch reports. The retired pathologist, Fazlul Sarkar, had gained notoriety both for the investigation’s results and for his unsuccessful 2016 lawsuit against PubPeer, which sought to force the online discussion site to reveal the identity of commenters who alleged misconduct on his part.

See “PubPeer Wins Appeal on Anonymous Comments

The new retraction, dated December 22, is of a 2012 study in Cancer Letters titled “Increased Ras GTPase activity is regulated by miRNAs that can be attenuated by CDF treatment in pancreatic cancer cells.” The retraction notice explains that the Wayne State investigation found a discrepancy between the originally collected data and those reported in two of the paper’s figures.

The 2015 Wayne State report recommended that 42 of Sarkar’s papers be retracted—of those, more than half remain intact, Retraction Watch notes.

Add a Comment

Avatar of: You



Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Popular Now

  1. How Gaining and Losing Weight Affects the Body
    Daily News How Gaining and Losing Weight Affects the Body

    Millions of measurements from 23 people who consumed extra calories every day for a month reveal changes in proteins, metabolites, and gut microbiota that accompany shifts in body mass.

  2. That Other CRISPR Patent Dispute
    Daily News That Other CRISPR Patent Dispute

    The Broad Institute and Rockefeller University disagree over which scientists should be named as inventors on certain patents involving the gene-editing technology.

  3. Neurons Use Virus-Like Proteins to Transmit Information
  4. EPO Revokes Broad’s CRISPR Patent
    The Nutshell EPO Revokes Broad’s CRISPR Patent

    Shortly after ruling out the earliest priority dates on a foundational patent for CRISPR gene-editing technology, the European Patent Office rescinded the patent entirely—and more are likely to follow.